- United States
- /
- Pharma
- /
- NYSE:RFL
Rafael Holdings Third Quarter 2025 Earnings: US$0.19 loss per share (vs US$1.36 loss in 3Q 2024)
Rafael Holdings (NYSE:RFL) Third Quarter 2025 Results
Key Financial Results
- Net loss: US$4.78m (loss narrowed by 85% from 3Q 2024).
- US$0.19 loss per share (improved from US$1.36 loss in 3Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period

Rafael Holdings shares are up 37% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Rafael Holdings has 4 warning signs (and 2 which are a bit unpleasant) we think you should know about.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:RFL
Rafael Holdings
Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel.
Adequate balance sheet with slight risk.
Market Insights
Weekly Picks

Is this the AI replacing marketing professionals?

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

The academically fascinating Tesla
Eli Lilly: A Pipeline-Driven Growth Story Trading 30% Below What the Business Is Actually Worth
Recently Updated Narratives

The Most Wonderful Monopoly in the Most Dangerous Neighbourhood on Earth
DXN: New executive director appointment reinforces continuity and strengthens execution at board level
Alibaba’s Next Act: Reclaiming Growth by Going Back to Its Online Roots
Popular Narratives
SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

